Global Gastrointestinal Disorder Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 104

Published Date: 06 Jan 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Gastrointestinal Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gastrointestinal Disorder Therapeutics market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospitals accounting for  % of the Gastrointestinal Disorder Therapeutics global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Irritable Bowel Syndrome (IBS) segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Gastrointestinal Disorder Therapeutics include AstraZeneca, Takeda Pharmaceutical, Johnson & Johnson, Eisai, and Abbott Laboratories, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Gastrointestinal Disorder Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Irritable Bowel Syndrome (IBS)
    Chronic Constipation (CC)
    Ulcerative Colitis (UC)

Market segment by Application, can be divided into
    Hospitals
    Clinics
    Others

Market segment by players, this report covers
    AstraZeneca
    Takeda Pharmaceutical
    Johnson & Johnson
    Eisai
    Abbott Laboratories
    Salix Pharmaceuticals
    Bausch Health
    Allergan
    Bayer
    UCB
    AbbVie
    GlaxoSmithKline
    Astellas Pharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gastrointestinal Disorder Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gastrointestinal Disorder Therapeutics, with revenue, gross margin and global market share of Gastrointestinal Disorder Therapeutics from 2019 to 2022.
Chapter 3, the Gastrointestinal Disorder Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gastrointestinal Disorder Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gastrointestinal Disorder Therapeutics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Disorder Therapeutics
    1.2 Classification of Gastrointestinal Disorder Therapeutics by Type
        1.2.1 Overview: Global Gastrointestinal Disorder Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type in 2021
        1.2.3 Irritable Bowel Syndrome (IBS)
        1.2.4 Chronic Constipation (CC)
        1.2.5 Ulcerative Colitis (UC)
    1.3 Global Gastrointestinal Disorder Therapeutics Market by Application
        1.3.1 Overview: Global Gastrointestinal Disorder Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Gastrointestinal Disorder Therapeutics Market Size & Forecast
    1.5 Global Gastrointestinal Disorder Therapeutics Market Size and Forecast by Region
        1.5.1 Global Gastrointestinal Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Gastrointestinal Disorder Therapeutics Market Size by Region, (2017-2022)
        1.5.3 North America Gastrointestinal Disorder Therapeutics Market Size and Prospect (2017-2028)
        1.5.4 Europe Gastrointestinal Disorder Therapeutics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size and Prospect (2017-2028)
        1.5.6 South America Gastrointestinal Disorder Therapeutics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Gastrointestinal Disorder Therapeutics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gastrointestinal Disorder Therapeutics Market Drivers
        1.6.2 Gastrointestinal Disorder Therapeutics Market Restraints
        1.6.3 Gastrointestinal Disorder Therapeutics Trends Analysis

2 Company Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Gastrointestinal Disorder Therapeutics Product and Solutions
        2.1.4 AstraZeneca Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 AstraZeneca Recent Developments and Future Plans
    2.2 Takeda Pharmaceutical
        2.2.1 Takeda Pharmaceutical Details
        2.2.2 Takeda Pharmaceutical Major Business
        2.2.3 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Solutions
        2.2.4 Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Takeda Pharmaceutical Recent Developments and Future Plans
    2.3 Johnson & Johnson
        2.3.1 Johnson & Johnson Details
        2.3.2 Johnson & Johnson Major Business
        2.3.3 Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Solutions
        2.3.4 Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Johnson & Johnson Recent Developments and Future Plans
    2.4 Eisai
        2.4.1 Eisai Details
        2.4.2 Eisai Major Business
        2.4.3 Eisai Gastrointestinal Disorder Therapeutics Product and Solutions
        2.4.4 Eisai Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Eisai Recent Developments and Future Plans
    2.5 Abbott Laboratories
        2.5.1 Abbott Laboratories Details
        2.5.2 Abbott Laboratories Major Business
        2.5.3 Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Solutions
        2.5.4 Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Abbott Laboratories Recent Developments and Future Plans
    2.6 Salix Pharmaceuticals
        2.6.1 Salix Pharmaceuticals Details
        2.6.2 Salix Pharmaceuticals Major Business
        2.6.3 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Solutions
        2.6.4 Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Salix Pharmaceuticals Recent Developments and Future Plans
    2.7 Bausch Health
        2.7.1 Bausch Health Details
        2.7.2 Bausch Health Major Business
        2.7.3 Bausch Health Gastrointestinal Disorder Therapeutics Product and Solutions
        2.7.4 Bausch Health Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Bausch Health Recent Developments and Future Plans
    2.8 Allergan
        2.8.1 Allergan Details
        2.8.2 Allergan Major Business
        2.8.3 Allergan Gastrointestinal Disorder Therapeutics Product and Solutions
        2.8.4 Allergan Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Allergan Recent Developments and Future Plans
    2.9 Bayer
        2.9.1 Bayer Details
        2.9.2 Bayer Major Business
        2.9.3 Bayer Gastrointestinal Disorder Therapeutics Product and Solutions
        2.9.4 Bayer Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Bayer Recent Developments and Future Plans
    2.10 UCB
        2.10.1 UCB Details
        2.10.2 UCB Major Business
        2.10.3 UCB Gastrointestinal Disorder Therapeutics Product and Solutions
        2.10.4 UCB Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 UCB Recent Developments and Future Plans
    2.11 AbbVie
        2.11.1 AbbVie Details
        2.11.2 AbbVie Major Business
        2.11.3 AbbVie Gastrointestinal Disorder Therapeutics Product and Solutions
        2.11.4 AbbVie Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 AbbVie Recent Developments and Future Plans
    2.12 GlaxoSmithKline
        2.12.1 GlaxoSmithKline Details
        2.12.2 GlaxoSmithKline Major Business
        2.12.3 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Solutions
        2.12.4 GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 GlaxoSmithKline Recent Developments and Future Plans
    2.13 Astellas Pharma
        2.13.1 Astellas Pharma Details
        2.13.2 Astellas Pharma Major Business
        2.13.3 Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Solutions
        2.13.4 Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Astellas Pharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gastrointestinal Disorder Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Gastrointestinal Disorder Therapeutics Players Market Share in 2021
        3.2.2 Top 10 Gastrointestinal Disorder Therapeutics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Gastrointestinal Disorder Therapeutics Players Head Office, Products and Services Provided
    3.4 Gastrointestinal Disorder Therapeutics Mergers & Acquisitions
    3.5 Gastrointestinal Disorder Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Gastrointestinal Disorder Therapeutics Revenue and Market Share by Type (2017-2022)
    4.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Application (2017-2022)
    5.2 Global Gastrointestinal Disorder Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2028)
    6.2 North America Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2028)
    6.3 North America Gastrointestinal Disorder Therapeutics Market Size by Country
        6.3.1 North America Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2028)
        6.3.2 United States Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        6.3.3 Canada Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Gastrointestinal Disorder Therapeutics Market Size by Country
        7.3.1 Europe Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2028)
        7.3.2 Germany Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        7.3.3 France Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        7.3.5 Russia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        7.3.6 Italy Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Disorder Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Region (2017-2028)
        8.3.2 China Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        8.3.3 Japan Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        8.3.5 India Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        8.3.7 Australia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2028)
    9.2 South America Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2028)
    9.3 South America Gastrointestinal Disorder Therapeutics Market Size by Country
        9.3.1 South America Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2028)
        9.3.2 Brazil Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Disorder Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2028)
        10.3.2 Turkey Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)
        10.3.4 UAE Gastrointestinal Disorder Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gastrointestinal Disorder Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Gastrointestinal Disorder Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Gastrointestinal Disorder Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Gastrointestinal Disorder Therapeutics Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Region (2023-2028)
    Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
    Table 7. AstraZeneca Major Business
    Table 8. AstraZeneca Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 9. AstraZeneca Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Takeda Pharmaceutical Corporate Information, Head Office, and Major Competitors
    Table 11. Takeda Pharmaceutical Major Business
    Table 12. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 13. Takeda Pharmaceutical Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
    Table 15. Johnson & Johnson Major Business
    Table 16. Johnson & Johnson Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 17. Johnson & Johnson Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Eisai Corporate Information, Head Office, and Major Competitors
    Table 19. Eisai Major Business
    Table 20. Eisai Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 21. Eisai Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
    Table 23. Abbott Laboratories Major Business
    Table 24. Abbott Laboratories Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 25. Abbott Laboratories Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 27. Salix Pharmaceuticals Major Business
    Table 28. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 29. Salix Pharmaceuticals Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Bausch Health Corporate Information, Head Office, and Major Competitors
    Table 31. Bausch Health Major Business
    Table 32. Bausch Health Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 33. Bausch Health Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Allergan Corporate Information, Head Office, and Major Competitors
    Table 35. Allergan Major Business
    Table 36. Allergan Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 37. Allergan Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Bayer Corporate Information, Head Office, and Major Competitors
    Table 39. Bayer Major Business
    Table 40. Bayer Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 41. Bayer Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. UCB Corporate Information, Head Office, and Major Competitors
    Table 43. UCB Major Business
    Table 44. UCB Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 45. UCB Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. AbbVie Corporate Information, Head Office, and Major Competitors
    Table 47. AbbVie Major Business
    Table 48. AbbVie Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 49. AbbVie Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 51. GlaxoSmithKline Major Business
    Table 52. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 53. GlaxoSmithKline Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Astellas Pharma Corporate Information, Head Office, and Major Competitors
    Table 55. Astellas Pharma Major Business
    Table 56. Astellas Pharma Gastrointestinal Disorder Therapeutics Product and Solutions
    Table 57. Astellas Pharma Gastrointestinal Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. Global Gastrointestinal Disorder Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 59. Global Gastrointestinal Disorder Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 60. Breakdown of Gastrointestinal Disorder Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. Gastrointestinal Disorder Therapeutics Players Head Office, Products and Services Provided
    Table 62. Gastrointestinal Disorder Therapeutics Mergers & Acquisitions in the Past Five Years
    Table 63. Gastrointestinal Disorder Therapeutics New Entrants and Expansion Plans
    Table 64. Global Gastrointestinal Disorder Therapeutics Revenue (USD Million) by Type (2017-2022)
    Table 65. Global Gastrointestinal Disorder Therapeutics Revenue Share by Type (2017-2022)
    Table 66. Global Gastrointestinal Disorder Therapeutics Revenue Forecast by Type (2023-2028)
    Table 67. Global Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022)
    Table 68. Global Gastrointestinal Disorder Therapeutics Revenue Forecast by Application (2023-2028)
    Table 69. North America Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 70. North America Gastrointestinal Disorder Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 71. North America Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 72. North America Gastrointestinal Disorder Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 73. North America Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 74. North America Gastrointestinal Disorder Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 75. Europe Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 76. Europe Gastrointestinal Disorder Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 77. Europe Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 78. Europe Gastrointestinal Disorder Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 79. Europe Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 80. Europe Gastrointestinal Disorder Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 81. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 82. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 83. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 84. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 85. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Region (2017-2022) & (USD Million)
    Table 86. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue by Region (2023-2028) & (USD Million)
    Table 87. South America Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 88. South America Gastrointestinal Disorder Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 89. South America Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 90. South America Gastrointestinal Disorder Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 91. South America Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 92. South America Gastrointestinal Disorder Therapeutics Revenue by Country (2023-2028) & (USD Million)
    Table 93. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Type (2017-2022) & (USD Million)
    Table 94. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Type (2023-2028) & (USD Million)
    Table 95. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Application (2017-2022) & (USD Million)
    Table 96. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Application (2023-2028) & (USD Million)
    Table 97. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Country (2017-2022) & (USD Million)
    Table 98. Middle East & Africa Gastrointestinal Disorder Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Gastrointestinal Disorder Therapeutics Picture
    Figure 2. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Type in 2021
    Figure 3. Irritable Bowel Syndrome (IBS)
    Figure 4. Chronic Constipation (CC)
    Figure 5. Ulcerative Colitis (UC)
    Figure 6. Gastrointestinal Disorder Therapeutics Revenue Market Share by Application in 2021
    Figure 7. Hospitals Picture
    Figure 8. Clinics Picture
    Figure 9. Others Picture
    Figure 10. Global Gastrointestinal Disorder Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 11. Global Gastrointestinal Disorder Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
    Figure 12. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 13. Global Gastrointestinal Disorder Therapeutics Revenue Market Share by Region in 2021
    Figure 14. North America Gastrointestinal Disorder Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 15. Europe Gastrointestinal Disorder Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. South America Gastrointestinal Disorder Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Middle East and Africa Gastrointestinal Disorder Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Gastrointestinal Disorder Therapeutics Market Drivers
    Figure 20. Gastrointestinal Disorder Therapeutics Market Restraints
    Figure 21. Gastrointestinal Disorder Therapeutics Market Trends
    Figure 22. AstraZeneca Recent Developments and Future Plans
    Figure 23. Takeda Pharmaceutical Recent Developments and Future Plans
    Figure 24. Johnson & Johnson Recent Developments and Future Plans
    Figure 25. Eisai Recent Developments and Future Plans
    Figure 26. Abbott Laboratories Recent Developments and Future Plans
    Figure 27. Salix Pharmaceuticals Recent Developments and Future Plans
    Figure 28. Bausch Health Recent Developments and Future Plans
    Figure 29. Allergan Recent Developments and Future Plans
    Figure 30. Bayer Recent Developments and Future Plans
    Figure 31. UCB Recent Developments and Future Plans
    Figure 32. AbbVie Recent Developments and Future Plans
    Figure 33. GlaxoSmithKline Recent Developments and Future Plans
    Figure 34. Astellas Pharma Recent Developments and Future Plans
    Figure 35. Global Gastrointestinal Disorder Therapeutics Revenue Share by Players in 2021
    Figure 36. Gastrointestinal Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 37. Global Top 3 Players Gastrointestinal Disorder Therapeutics Revenue Market Share in 2021
    Figure 38. Global Top 10 Players Gastrointestinal Disorder Therapeutics Revenue Market Share in 2021
    Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 40. Global Gastrointestinal Disorder Therapeutics Revenue Share by Type in 2021
    Figure 41. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Type (2023-2028)
    Figure 42. Global Gastrointestinal Disorder Therapeutics Revenue Share by Application in 2021
    Figure 43. Global Gastrointestinal Disorder Therapeutics Market Share Forecast by Application (2023-2028)
    Figure 44. North America Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2017-2028)
    Figure 45. North America Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2017-2028)
    Figure 46. North America Gastrointestinal Disorder Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 47. United States Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Canada Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Mexico Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Europe Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2017-2028)
    Figure 51. Europe Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2017-2028)
    Figure 52. Europe Gastrointestinal Disorder Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 53. Germany Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. France Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. United Kingdom Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Russia Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Italy Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Asia-Pacific Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2017-2028)
    Figure 59. Asia-Pacific Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2017-2028)
    Figure 60. Asia-Pacific Gastrointestinal Disorder Therapeutics Revenue Market Share by Region (2017-2028)
    Figure 61. China Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Japan Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South Korea Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. India Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Southeast Asia Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. Australia Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. South America Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2017-2028)
    Figure 68. South America Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2017-2028)
    Figure 69. South America Gastrointestinal Disorder Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 70. Brazil Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Argentina Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales Market Share by Type (2017-2028)
    Figure 73. Middle East and Africa Gastrointestinal Disorder Therapeutics Sales Market Share by Application (2017-2028)
    Figure 74. Middle East and Africa Gastrointestinal Disorder Therapeutics Revenue Market Share by Country (2017-2028)
    Figure 75. Turkey Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Saudi Arabia Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. UAE Gastrointestinal Disorder Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Methodology
    Figure 79. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AstraZeneca
Takeda Pharmaceutical
Johnson & Johnson
Eisai
Abbott Laboratories
Salix Pharmaceuticals
Bausch Health
Allergan
Bayer
UCB
AbbVie
GlaxoSmithKline
Astellas Pharma

Related Reports

Global Gastrointestinal Disorder Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Gastrointestinal Disorder Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 19 Feb 2021

date Medical Care

The Gastrointestinal Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Gastrointestinal Disorder Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gastrointestinal Disorder Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Gastrointestinal Disorder Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

gastrointestinal disorder therapeutics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>